aTyr Pharma | LIFE - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Alterity Therapeutics Limited AUD 1.45M 703.96K 2025-12
Ardelyx USD 102.27M 26.35M 2026-03
aTyr Pharma USD 700.63K 81.56M 2026-03
Biogen USD 554.3M 128.2M 2026-03
Bristol-Myers Squibb USD 1.62B 564M 2026-03
Cipla INR 13.25B 101.8M 2025-12
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.43M 222K 2026-03
CSL USD 1.23B 498M 2025-12
Curis USD 1.34M 3.45M 2025-12
GlaxoSmithKline GBP 2.12B 558M 2026-03
Grifols EUR 320.45M 12.65M 2025-12
Lakefront Biotherapeutics EUR 35.5M 8.91M 2026-03
Novartis USD 3.14B 296M 2026-03
Roche Holding CHF 7.28B 3.99B 2025-12
United Therapeutics USD 156.6M 34M 2026-03
Xoma USD 11M 2.54M 2024-06